{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:00:19Z","timestamp":1792670419529,"version":"4.5.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001773","name":"UNSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This review aims to present a comprehensive synthesis of the existing treatment modalities for keratosis pilaris (KP) and evaluate their therapeutic efficacy. KP is a prevalent chronic dermatological condition typified by its unique \u2018chicken skin appearance\u2019, with the cheeks being the most commonly involved sites. Numerous therapeutic interventions have emerged, given its substantial prevalence and impact on skin aesthetics and psychological wellbeing. Nonetheless, a consistent therapeutic response has been challenging to achieve. This review endeavours to collate and critically appraise the current treatment landscape for KP. An exhaustive literature search was performed using databases such as Ovid, PubMed and Scopus. From an initial count of 459 articles identified after deduplication, 52 were selected for inclusion after a thorough full-text examination for articles with concrete outcome data highlighting the efficacies of different therapeutic modalities; articles that lacked data or were tangential to the core focus on KP treatment were excluded. The included articles were then catalogued based on the nature of treatment strategies and their respective outcomes. Among the various therapeutic interventions, laser and light modalities appear to be supported by the most substantial evidence base. Notably, the Nd:YAG (neodymium-doped yttrium\u2013aluminium\u2013garnet) laser, attributed to its longer wavelength, emerged as a preferred option. While other therapeutic avenues have also exhibited notable improvements in skin texture and discolouration relative to baseline, the inconsistency in outcome measures underscores the need for a standardized, KP-specific scoring system to foster a more coherent comparison across treatments. Based on the current evidence, Nd:YAG laser therapy demonstrates promising effectiveness with a relatively favourable side-effect profile. However, the landscape of KP treatment is multifaceted, and further studies are essential to solidify recommendations.<\/jats:p>","DOI":"10.1093\/ced\/llae066","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T20:55:00Z","timestamp":1709758500000},"page":"1105-1117","source":"Crossref","is-referenced-by-count":6,"title":["Keratosis pilaris treatment paradigms: assessing effectiveness across modalities"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-6343","authenticated-orcid":false,"given":"Pooi C","family":"Wong","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3876-5968","authenticated-orcid":false,"given":"Madeline A","family":"Wang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6720-0848","authenticated-orcid":false,"given":"Tangqi J","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St George Hospital, University of New South Wales , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2018-6378","authenticated-orcid":false,"given":"Hossein","family":"Akbarialiabad","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"},{"name":"Department of Dermatology, St George Hospital, University of New South Wales , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-0199","authenticated-orcid":false,"given":"D\u00e9d\u00e9e\u00a0F","family":"Murrell","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, University of New South Wales , Sydney, NSW , Australia"},{"name":"Department of Dermatology, St George Hospital, University of New South Wales , Sydney, NSW , Australia"},{"name":"The George Institute for Global Health , Sydney, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"2024091818142639100_llae066-B1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/B978-0-7020-3485-5.00016-4","volume-title":"Weedon\u2019s Skin Pathology","author":"Weedon","year":"2010","edition":"3rd edn"},{"key":"2024091818142639100_llae066-B2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-018-0368-3","article-title":"Keratosis pilaris and its subtypes: associations, new molecular and pharmacologic etiologies, and therapeutic options","volume":"19","author":"Wang","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"2024091818142639100_llae066-B3","first-page":"e18917","article-title":"A narrative review on the role of acids, steroids, and kinase inhibitors in the treatment of keratosis pilaris","volume":"13","author":"Reddy","year":"2021","journal-title":"Cureus"},{"key":"2024091818142639100_llae066-B4","author":"Pennycook"},{"key":"2024091818142639100_llae066-B5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000018425","article-title":"High body mass index, dry scaly leg skin and atopic conditions are highly associated with keratosis pilaris","volume":"201","author":"Yosipovitch","year":"2000","journal-title":"Dermatology"},{"key":"2024091818142639100_llae066-B6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0974-7753.111215","article-title":"Keratosis pilaris revisited: is it more than just a follicular keratosis?","volume":"4","author":"Thomas","year":"2012","journal-title":"Int J Trichol"},{"key":"2024091818142639100_llae066-B7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ajpath.2014.12.012","article-title":"Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency","volume":"185","author":"Gruber","year":"2015","journal-title":"Am J Pathol"},{"key":"2024091818142639100_llae066-B8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/09546634.2020.1818678","article-title":"Treatment of keratosis pilaris and its variants: a systematic review","volume":"33","author":"Maghfour","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2024091818142639100_llae066-B9","author":"Dong"},{"key":"2024091818142639100_llae066-B10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/archderm.142.12.1611","article-title":"Keratosis pilaris rubra: a common but underrecognized condition","volume":"142","author":"Marqueling","year":"2006","journal-title":"Arch Dermatol"},{"key":"2024091818142639100_llae066-B11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/0019-5154.182419","article-title":"Erythromelanosis follicularis faciei et colli \u2013 a cross-sectional, descriptive study","volume":"61","author":"Rather","year":"2016","journal-title":"Indian J Dermatol"},{"key":"2024091818142639100_llae066-B12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5021\/ad.2011.23.3.293","article-title":"A pilot study of Q-switched 1064-nm Nd:YAG laser treatment in the keratosis pilaris","volume":"23","author":"Park","year":"2011","journal-title":"Ann Dermatol"},{"key":"2024091818142639100_llae066-B13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/09546634.2012.660518","article-title":"Long-pulsed 1064-nm Nd:YAG laser significantly improves keratosis pilaris: a randomized, evaluator-blind study","volume":"24","author":"Saelim","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"2024091818142639100_llae066-B14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1524-4725.2010.01637.x","article-title":"Treatment of erythromelanosis follicularis faciei et colli using a dual-wavelength laser system: a split-face treatment","volume":"36","author":"Li","year":"2010","journal-title":"Dermatol Surg"},{"key":"2024091818142639100_llae066-B15","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1111\/jocd.15193","article-title":"Comparative study of the efficacy of fractional Er: YAG 2940\u2005nm laser and Q-switched Nd: YAG 1064\u2005nm laser in keratosis pilaris","volume":"21","author":"Bayazit","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2024091818142639100_llae066-B16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/DSS.0000000000003488","article-title":"Clinical and dermoscopic evaluation of trichloroacetic acid 20% versus long-pulsed 1064-nm Nd-YAG laser in the treatment of keratosis pilaris","volume":"48","author":"Hassan","year":"2022","journal-title":"Dermatol Surg"},{"key":"2024091818142639100_llae066-B17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/14764172.2011.581290","article-title":"Treatment of pigmented keratosis pilaris in Asian patients with a novel Q-switched Nd:YAG laser","volume":"13","author":"Kim","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"2024091818142639100_llae066-B18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/lsm.23184","article-title":"Innovative 1064-nm Nd:YAG laser significantly improves keratosis pilaris, a randomized, double-blind, sham-irradiation-controlled trial","volume":"52","author":"Maitriwong","year":"2020","journal-title":"Lasers Surg Med"},{"key":"2024091818142639100_llae066-B19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/DSS.0000000000003382","article-title":"Erythromelanosis follicularis faciei et colli treated with intense pulsed light","volume":"48","author":"Tsunoda","year":"2022","journal-title":"Dermatol Surg"},{"key":"2024091818142639100_llae066-B20","first-page":"17","article-title":"A pilot study of intense pulsed light treatment for keratosis pilaris","volume":"1","author":"Eyler","year":"2015","journal-title":"J Cell Immunol Serum Biol"},{"key":"2024091818142639100_llae066-B21","first-page":"E53","article-title":"Intense pulsed-light therapy significantly improves keratosis pilaris: a randomized, double-blind, sham irradiation-controlled trial","volume":"12","author":"Maitriwong","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"2024091818142639100_llae066-B22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1468-3083.2010.03772.x","article-title":"Keratosis pilaris rubra and keratosis pilaris atrophicans faciei treated with pulsed dye laser: report of 10 cases","volume":"25","author":"Alc\u00e1ntara Gonz\u00e1lez","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024091818142639100_llae066-B23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/14628830050516416","article-title":"Treatment of keratosis pilaris atrophicans with the pulsed tunable dye laser","volume":"2","author":"Clark","year":"2000","journal-title":"J Cutan Laser Ther"},{"key":"2024091818142639100_llae066-B24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/pde.12892","article-title":"Successful treatment of keratosis pilaris rubra with pulsed dye laser","volume":"33","author":"Schoch","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"2024091818142639100_llae066-B25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s10103-020-02956-w","article-title":"Comparative study between the efficacy of fractional CO2 laser, Q-switched Nd:YAG laser (1064\u2005nm), and both types in treatment of keratosis pilaris","volume":"35","author":"Sobhi","year":"2020","journal-title":"Lasers Med Sci"},{"key":"2024091818142639100_llae066-B26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/jocd.13140","article-title":"Clinical and dermoscopic evaluation of fractional carbon dioxide laser in management of keratosis pilaris in Egyptian type skin","volume":"19","author":"Ismail","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"2024091818142639100_llae066-B27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/14764172.2013.769276","article-title":"Combination of 595-nm pulsed dye laser, long-pulsed 755-nm alexandrite laser, and microdermabrasion treatment for keratosis pilaris: retrospective analysis of 26 Korean patients","volume":"15","author":"Lee","year":"2013","journal-title":"J Cosmet Laser Ther"},{"key":"2024091818142639100_llae066-B28","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s13555-022-00771-5","article-title":"Efficacy and safety of long-pulsed 755-nm alexandrite laser for keratosis pilaris: a split-body randomized clinical trial","volume":"12","author":"Li","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2024091818142639100_llae066-B29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2133.2002.493010.x","article-title":"Keratosis rubra pilaris responding to potassium titanyl phosphate laser","volume":"147","author":"Dawn","year":"2002","journal-title":"Br J Dermatol"},{"key":"2024091818142639100_llae066-B30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamadermatol.2014.2211","article-title":"Treatment of keratosis pilaris with 810-nm diode laser a randomized clinical trial","volume":"151","author":"Ibrahim","year":"2015","journal-title":"JAMA Dermatol"},{"key":"2024091818142639100_llae066-B31","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1111\/jocd.15088","article-title":"Treatment of keratosis pilaris rubra with 577-nm pro-yellow laser","volume":"21","author":"Temiz","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2024091818142639100_llae066-B32","first-page":"804","article-title":"Photopneumatic therapy for the treatment of keratosis pilaris","volume":"12","author":"Ciliberto","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"2024091818142639100_llae066-B33","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s13555-021-00611-y","article-title":"Urea in dermatology: a review of its emollient, moisturizing, keratolytic, skin barrier enhancing and antimicrobial properties","volume":"11","author":"Piquero-Casals","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2024091818142639100_llae066-B34","first-page":"CD011368","article-title":"Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne","volume":"5","author":"Liu","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2024091818142639100_llae066-B35","doi-asserted-by":"crossref","first-page":"205012","DOI":"10.1155\/2015\/205012","article-title":"Epidermal permeability barrier in the treatment of keratosis pilaris","volume":"2015","author":"Kootiratrakarn","year":"2015","journal-title":"Dermatol Res Pract"},{"issue":"6 Suppl.","key":"2024091818142639100_llae066-B36","article-title":"Evaluation of the efficacy of an exfoliating cleanser and urea-containing cream on keratosis pilaris using clinical and 3D image-based analysis","volume":"83","author":"Staubach","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2024091818142639100_llae066-B37","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.12998\/wjcc.v9.i18.4681","article-title":"Clinical outcomes and 5-year follow-up results of keratosis pilaris treated by a high concentration of glycolic acid","volume":"9","author":"Tian","year":"2021","journal-title":"World J Clin Cases"},{"key":"2024091818142639100_llae066-B38","first-page":"51","article-title":"Erythromelanosis follicularis faciei \u2013 a variant of keratosis pilaris?","volume":"13","author":"Volks","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4 Suppl. 1","key":"2024091818142639100_llae066-B39","first-page":"AB167","article-title":"Prospective right\/left comparison of azeleic acid and cetaphil for treatment of keratosis pilaris","volume":"66","author":"Yang","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2024091818142639100_llae066-B40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/pde.14963","article-title":"Keratosis pilaris rubra successfully treated with topical sirolimus: report of a case and review of the literature","volume":"39","author":"Eckburg","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"2024091818142639100_llae066-B41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jmedsci.jmedsci_356_20","article-title":"Efficacy of tacrolimus 0.1% ointment in keratosis pilaris: a prospective hospital based interventional study","volume":"42","author":"Tatavarthi","year":"2022","journal-title":"J Med Sci (Taiwan)"},{"issue":"3 Suppl.","key":"2024091818142639100_llae066-B42","first-page":"P151","article-title":"A clinical study to evaluate the efficacy of tacrolimus 0.1% for the treatment of keratosis pilaris","volume":"52","author":"Conley","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"2024091818142639100_llae066-B43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1525-1470.2011.01497.x","article-title":"A comparative trial comparing the efficacy of tacrolimus 0.1% ointment with Aquaphor ointment for the treatment of keratosis pilaris","volume":"28","author":"Breithaupt","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"2024091818142639100_llae066-B44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archderm.1994.01690040073011","article-title":"Clinical findings, cutaneous pathology, and response to therapy in 21 patients with keratosis pilaris atrophicans","volume":"130","author":"Baden","year":"1994","journal-title":"Arch Dermatol"},{"key":"2024091818142639100_llae066-B45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archderm.1995.01690170058008","article-title":"Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right\/left comparative study","volume":"131","author":"Kragballe","year":"1995","journal-title":"Arch Dermatol"},{"key":"2024091818142639100_llae066-B46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/12034754211035091","article-title":"A clinician's guide to topical retinoids","volume":"26","author":"Motamedi","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"2024091818142639100_llae066-B47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/ced.15020","article-title":"A detailed regimen of isotretinoin for the successful treatment of severe keratosis pilaris","volume":"47","author":"Kirchner","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2024091818142639100_llae066-B48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5021\/ad.2018.30.1.116","article-title":"A case of atrophoderma vermiculatum showing a good response to topical tretinoin","volume":"30","author":"Lee","year":"2018","journal-title":"Ann Dermatol"},{"key":"2024091818142639100_llae066-B49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1067\/mjd.2002.122733","article-title":"Treating keratosis pilaris","volume":"47","author":"Gerbig","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"2024091818142639100_llae066-B50","doi-asserted-by":"crossref","first-page":"P39","DOI":"10.1016\/j.jaad.2003.10.158","article-title":"Tazarotene 0.05% cream for the treatment of keratosis pilaris","volume":"50","author":"Bogle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2024091818142639100_llae066-B51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.12891\/ceog16922014","article-title":"Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate","volume":"41","author":"Check","year":"2014","journal-title":"Clin Exp Obstet Gynecol"},{"key":"2024091818142639100_llae066-B52","first-page":"250","article-title":"Polyester sponge adjunct in acne management","volume":"3","author":"Diamant","year":"1980","journal-title":"Clin Ther"},{"issue":"2, Suppl. 2","key":"2024091818142639100_llae066-B53","first-page":"AB35","article-title":"Treatment of keratosis pilaris with a novel polymer-based skin coating","volume":"58","author":"Jason","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4 Suppl. 1","key":"2024091818142639100_llae066-B54","first-page":"AB49","article-title":"Efficacy and safety of a sonic skin care brush on keratosis pilaris","volume":"68","author":"Kearney","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2024091818142639100_llae066-B55","first-page":"210","article-title":"The use of silicones in dermatology","volume":"81","author":"LeVan","year":"1954","journal-title":"Calif Med"},{"key":"2024091818142639100_llae066-B56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/09546634.2012.671914","article-title":"Combination peel with incorporated fractional prickle coral calcium for the treatment of keratosis pilaris: a pilot study","volume":"25","author":"Park","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"2024091818142639100_llae066-B57","first-page":"554","article-title":"Chlorine dioxide complex cleanser: a new agent with rapid efficacy for keratosis pilaris","volume":"17","author":"Zirwas","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"2024091818142639100_llae066-B58","first-page":"285","article-title":"Dermal microflora restoration with ammonia-oxidizing bacteria Nitrosomonas eutropha in the treatment of keratosis pilaris: a randomized clinical trial","volume":"17","author":"Lee","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"274","key":"2024091818142639100_llae066-B59","article-title":"[Keratosis pilaris]","volume":"33","author":"Agharbi","year":"2019","journal-title":"Pan Afr Med J"},{"key":"2024091818142639100_llae066-B60","first-page":"1211","article-title":"Diabetic skin changes can benefit from moisturizer and cleanser use: a review","volume":"18","author":"Kirsner","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"2024091818142639100_llae066-B61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/14764172.2010.502456","article-title":"Keratosis pilaris atrophicans: treatment with intense pulsed light in four patients","volume":"12","author":"Rodr\u00edguez-Lojo","year":"2010","journal-title":"J Cosmet Laser Ther"},{"issue":"S26","key":"2024091818142639100_llae066-B62","first-page":"1","article-title":"Keratosis pilaris atrophicans: reduction of redness and roughness using PDL and IPL. American Society for Laser Medicine and Surgery Abstracts","volume":"47","author":"Shurman","year":"2015","journal-title":"Lasers Surg Med"},{"key":"2024091818142639100_llae066-B63","first-page":"72","article-title":"The efficacy of IPL and ammonium lactate 14% versus ammonium lactate alone in the treatment of keratosis pilaris","volume":"23","author":"Siadat","year":"2020","journal-title":"Iran J Dermatol"},{"key":"2024091818142639100_llae066-B64","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1524-4725.2009.01282.x","article-title":"Successful treatment of severe keratosis pilaris rubra with a 595-nm pulsed dye laser","volume":"35","author":"Kaune","year":"2009","journal-title":"Dermatol Surg"},{"key":"2024091818142639100_llae066-B65","doi-asserted-by":"crossref","first-page":"1928540","DOI":"10.1155\/2016\/1928540","article-title":"Fractional carbon dioxide laser for keratosis pilaris: a single-blind, randomized, comparative study","volume":"2016","author":"Vachiramon","year":"2016","journal-title":"Biomed Res Int"},{"key":"2024091818142639100_llae066-B66","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/jocd.13387","article-title":"Two is better than one: the combined effects of glycolic acid and salicylic acid on acne-related disorders","volume":"19","author":"Wiegmann","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"2024091818142639100_llae066-B67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archderm.1955.01540280026004","article-title":"Treatment for ulerythema ophryogenes with hydrocortisone ointment","volume":"71","author":"Edelstein","year":"1955","journal-title":"AMA Arch Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llae066\/58393832\/llae066.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/10\/1105\/59183558\/llae066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/10\/1105\/59183558\/llae066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T18:14:47Z","timestamp":1726683287000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/10\/1105\/7623274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":67,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,3,6]]},"published-print":{"date-parts":[[2024,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llae066","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,3,6]]}}}